SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
457.10    3.50 (0.77%)
Bid:
457.00
Ask:
457.20
Spread: 0.20 (0.044%)
Market Cap: £11.50b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Q4 2020 Acquisitions and Trading Update

8 Jan 2021 07:00

RNS Number : 0002L
Rentokil Initial PLC
08 January 2021
 

 

8 January 2021

Rentokil Initial plc - Q4 2020 Acquisitions and Trading Update

A very strong end to the year for M&A in our key North America pest control market with continued strong trading boosted by momentum in disinfection services

Rentokil Initial plc (FTSE: RTO, "the Company") announces today the acquisition of Environmental Pest Service ('EPS'), a full-service, commercial and residential pest control company based in Tampa, Florida.

EPS was ranked 15th in the PCT Magazine 2020 Top 100 listing of leading US pest control companies and generated annualised revenues of c.$82m (£60m) in 2020. EPS employs c.640 people (of which 386 are in service roles) in 30 branches across four separate regions: East Florida; West Florida; North Georgia; and North Carolina. It has two brand names, Arrow Environmental and Bug Out.

In addition to the acquisition of EPS, we have acquired a further eight high quality pest control companies in North America in Q4, with combined annualised revenues of c.$62m (c.£48m) in 2020.

Total acquisitions in 2020

For the full year ended 31 December 2020, we have acquired 23 new businesses, with annualised revenues of over £150m, for a cash spend of c.£180m (of which c.£150m was in H2). This excludes the consideration for EPS which was paid at the beginning of January 2021.

Announcement of Preliminary Results and Updated Guidance for 2020

Rentokil Initial plc will announce its 2020 Preliminary results on Thursday, 4 March. In our Q3 Trading Statement last October, we indicated that despite continued uncertainty across our business as a result of the ongoing pandemic, we were hopeful of being able to maintain the momentum we had seen in Q3 into the fourth quarter which would result in an outcome for the full year at least in line with expectations. Trading across both our Hygiene and Pest Control categories has continued to be strong in Q4 - primarily reflecting continued strong sales from one-off disinfection services - and we now expect the final outcome for the year to be slightly above the top end of the range of current market expectations for Adjusted PBTA*.

We are looking to the future with confidence. However, while global vaccination programmes offer hope that we will see an end to the pandemic, the financial outlook for 2021 inevitably remains uncertain, in particular with limited visibility on the sustainability of one-off disinfection services, the recent strengthening of sterling, and the undetermined impacts arising from recently rising cases of COVID-19 globally and new and prolonged country lockdowns. We look forward to providing a further update with our full year results on 4 March.

Andy Ransom, Chief Executive of Rentokil Initial plc, said:

"Despite the impact of COVID-19 on our business in 2020, we have exited the year in a strong position, with the trading momentum of Q3 continuing throughout Q4 and with an excellent overall delivery of M&A, which significantly accelerated as the year drew to a close. We have gained approximately 2000 new colleagues from acquisitions in 2020, and I am delighted to welcome them all to Rentokil Initial.

"I am also very pleased to announce our acquisition of Environmental Pest Service. EPS is a high-quality company of significant scale with a strong reputation for service delivery and technical ability, and with a culture which will make an excellent fit with our own. This acquisition is very much in line with our strategy to acquire pest control businesses that build customer density and add to our scale in key local markets - by acquiring EPS we can immediately add density, provide improved customer service, and provide incremental revenue to several of our sub-scale existing Rentokil locations on the Florida Gulf Coast, as well as build on our existing presence in north eastern Florida, metro Atlanta and North Carolina."

Investor / Analyst enquiries:

Katharine Rycroft, Investor Relations

Rentokil Initial plc

07811 270 734

Media enquiries:

Malcolm Padley, Corporate Communications

Rentokil Initial plc

07788 978 199

 

* Our Company-compiled current range of analyst forecasts for Adjusted PBTA for 2020 is £292m to £337m.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEAAFXESLFEAA
Date   Source Headline
28th Jul 20253:00 pmRNSHolding(s) in Company
10th Jul 202511:00 amRNSHolding(s) in Company
1st Jul 202510:25 amRNSTotal Voting Rights
10th Jun 202510:05 amRNSAdditional Listing
3rd Jun 20254:00 pmRNSDirector/PDMR Shareholding
28th May 20257:00 amRNSSale of France Workwear
19th May 20252:30 pmRNSDirector/PDMR Shareholding
7th May 20254:15 pmRNSResult of AGM
7th May 20257:01 amRNSDirectorate Change: Appointment of NEDs
7th May 20257:00 amRNSDirectorate Change: Chief Executive to retire
28th Apr 20252:30 pmRNSIssue of Debt
17th Apr 20252:20 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 Trading Update
9th Apr 202510:25 amRNSHolding(s) in Company
1st Apr 20252:15 pmRNSNotice of Q1 Trading Update and Management Call
1st Apr 202510:25 amRNSBlock listing Interim Review
27th Mar 202510:25 amRNSDirector/PDMR Shareholding
26th Mar 202510:30 amRNSAnnual Financial Report
14th Mar 202510:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
28th Jan 20257:00 amRNSTrading Update (unaudited)
14th Jan 202511:15 amRNSHolding(s) in Company
13th Jan 202511:15 amRNSHolding(s) in Company
13th Dec 20249:30 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSDirectorate Change
12th Nov 202410:30 amRNSHolding(s) in Company
8th Nov 202410:30 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSQ3 Trading Update
1st Oct 20242:00 pmRNSBlock listing Interim Review
25th Sep 20247:00 amRNSAppointment of Non-Executive Director
19th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSTrading Update
10th Sep 202410:30 amRNSHolding(s) in Company
5th Sep 202411:08 amRNSHolding(s) in Company
25th Jul 20247:00 amRNS2024 Interim Results
10th Jul 20244:35 pmRNSHolding(s) in Company
26th Jun 20245:12 pmRNSDirector/PDMR Shareholding
26th Jun 202411:08 amRNSHolding(s) in Company
17th May 20243:30 pmRNSDirector/PDMR Shareholding
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.